81
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trial

, , , , , , , , & show all
Pages 211-221 | Published online: 29 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lanfranco D’elia, Ersilia La Fata, Arcangelo Iannuzzi & Paolo O. Rubba. (2018) Effect of statin therapy on pulse wave velocity: A meta-analysis of randomized controlled trials. Clinical and Experimental Hypertension 40:7, pages 601-608.
Read now

Articles from other publishers (18)

Alberto E. Muñoz, Mariano Cartier & Ayelén B. Kisch. 2022. Pharmacotherapy for Liver Cirrhosis and Its Complications. Pharmacotherapy for Liver Cirrhosis and Its Complications 179 204 .
Mona Alidadi, Fabrizio Montecucco, Tannaz Jamialahmadi, Khalid Al-Rasadi, Thomas P. Johnston & Amirhossein Sahebkar. (2021) Beneficial Effect of Statin Therapy on Arterial Stiffness. BioMed Research International 2021, pages 1-19.
Crossref
Matthias H. Urban, Nicole Kreibich, Andreas Gleiss, Georg‐Christian Funk, Sylvia Hartl & Otto C. Burghuber. (2020) Effects of roflumilast on arterial stiffness in COPD ( ELASTIC ): A randomized trial . Respirology 26:2, pages 153-160.
Crossref
Jaime Bosch, Jordi Gracia-Sancho & Juan G Abraldes. (2020) Cirrhosis as new indication for statins. Gut 69:5, pages 953-962.
Crossref
Aleksey Mikhailovich Chaulin, Julia Vladimirovna Grigoryeva & Dmitriy Viktorovich Duplyakov. (2020) COMBORIDITY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND CARDIOVASCULAR DISEASES: GENERAL FACTORS, PATHOPHYSIOLOGICAL MECHANISMS AND CLINICAL SIGNIFICANCE. Journal of Clinical Practice.
Crossref
L. G. Ambatiello & I. E. Chazova. (2020) Cardiovascular and chronic obstructive pulmonary diseases: pathophysiological processes and treatment tactics. Terapevticheskii arkhiv 92:3, pages 78-83.
Crossref
Yongbin Lu, Ruixia Chang, Jia Yao, Xinni Xu, Yongjun Teng & Ning Cheng. (2019) Effectiveness of long-term using statins in COPD – a network meta-analysis. Respiratory Research 20:1.
Crossref
Aisling Walsh, Lucy Perrem, Ali S Khashan, Michael T Henry & Muireann Ni Chroinin. (2019) Statins versus placebo for people with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2019:7.
Crossref
Charlotte Andersson, Peter Wæde Hansen, Ida E. Steffensen, Charlotte Andreasen, Peter E. Weeke, Lars Køber, Gunnar H. Gislason & Christian Torp-Pedersen. (2019) Mortality associated with cardiovascular drugs in patients with chronic obstructive pulmonary disease and right-sided heart failure – A danish nationwide registry-based study. European Journal of Internal Medicine 63, pages 56-61.
Crossref
Pinelopi Grigoropoulou, Anastasios Tentolouris, Ioanna Eleftheriadou, Dimitrios Tsilingiris, Charalambos Vlachopoulos, Maria Sykara & Nikolaos Tentolouris. (2018) Effect of 12-month intervention with low-dose atorvastatin on pulse wave velocity in subjects with type 2 diabetes and dyslipidaemia. Diabetes and Vascular Disease Research 16:1, pages 38-46.
Crossref
Ann D Morgan, Rosita Zakeri & Jennifer K Quint. (2018) Defining the relationship between COPD and CVD: what are the implications for clinical practice?. Therapeutic Advances in Respiratory Disease 12, pages 175346581775052.
Crossref
Wen Zhang, Yi Zhang, Chuan-Wei Li, Paul Jones, Chen Wang & Ye Fan. (2017) Effect of Statins on COPD. Chest 152:6, pages 1159-1168.
Crossref
Wen-Feng Li, Yu-Qing Huang, Cheng Huang & Ying-Qing Feng. (2017) Statins reduce all-cause mortality in chronic obstructive pulmonary disease: an updated systematic review and meta-analysis of observational studies. Oncotarget 8:42, pages 73000-73008.
Crossref
Li Zuo, Chia-Chen Chuang, Alexander D. Clark, Davis E. Garrison, Jamie L. Kuhlman & David C. Sypert. 2017. Pulmonary Vasculature Redox Signaling in Health and Disease. Pulmonary Vasculature Redox Signaling in Health and Disease 399 411 .
Malay Sarkar. (2016) Chronic Obstructive Pulmonary Disease and Arterial Stiffness. EMJ Respiratory, pages 114-121.
Crossref
Mona Bafadhel & Richard E.K. Russell. (2016) Are COPD and cardiovascular disease fundamentally intertwined?. European Respiratory Journal 47:5, pages 1307-1309.
Crossref
Juan G. Abraldes, Candid Villanueva, Carles Aracil, Juan Turnes, Manuel Hernandez-Guerra, Joan Genesca, Manuel Rodriguez, Jose Castellote, Juan Carlos García-Pagán, Ferran Torres, Jose Luis Calleja, Agustin Albillos, Jaime Bosch, Salvador Augustin, Elba Llop, Dalia Morales Arraez, Goretti Hernández Mesa, Javier Martinez, Enric Reverter, Susana Seijo, Fanny Turon, Josep Miñana, Juan Buenestado, Josep M. Reñe, Carmen A. Navacués, Ramon Planas, Rosa M. Morillas, Pau Bellot, Jose Such, Mercedes Vergara, Angela Puente, Joaquin de la Pena, José Mera Calviño, Laura Rivas Moral, Oana Pavel, Edilmar Alvarado, Alba Ardevol, Anna Girbau, Alba Cachero, Joan Albert Arnaiz, Annalisa Berzigotti, Judit Pich, Jose Rios, Rosa Saenz, Laura Millan, Helena Beleta & Núria Ramos. (2016) Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis. Gastroenterology 150:5, pages 1160-1170.e3.
Crossref
Lourdes Cabrera & Juan G. Abraldes. (2016) Statins: the Panacea of Cirrhosis?. Current Hepatology Reports 15:1, pages 1-7.
Crossref